Chonnam National University Hospital
Gwangju, 61469, South Korea
NCT Number: NCT06397820
The aim of the study is to evaluate the clinical implications of artificial Intelligence (AI)-assisted quantitative coronary angiography (QCA) and positron emission tomography (PET)-derived myocardial blood flow in clinically indicated patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Gwangju, 61469, South Korea
Percutaneous coronary angiography (CAG) is a standard method for evaluating coronary artery disease. Traditionally, a reduction in the luminal diameter of the coronary arteries by 50% or more during angiography has been considered a significant stenotic lesion. However, the assessment of coronary artery stenosis is usually based on visual estimation by the operator in daily routine clinical practice, which interferes with the objective evaluation.
Quantitative coronary angiography (QCA) has been developed to overcome this limitation. This technique involves the software-based analysis of coronary images obtained through CAG. The previous study showed that there was low concordance between the QCA and visual estimation of coronary artery stenosis (Kappa=0.63) and a reclassification rate of approximately 20%. Furthermore, visual assessments tended to overestimate the degree of coronary artery stenosis, particularly in complex lesions such as bifurcation lesions.
However, there are some limitations to adopting QCA in our daily routine practice. The QCA cannot analyze coronary images on-site and is not fully automated, requiring manual adjustments by humans. Recent advancements have led to the development of artificial intelligence (AI)-based QCA software, which achieves complete automation in the analysis process and provides real-time objective evaluations of coronary artery stenosis.
This study aims to examine the clinical significance of AI-QCA by assessing the correlation between the degree of coronary stenosis detected by AI-QCA and myocardial blood flow abnormalities observed in 13NH3-Ammonia PET scans in patients with coronary artery disease.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Revascularization by percutaneous coronary intervention for vessels with decreased PET-derived flow indexes
Time frame: Immediate after AI-QCA and PET exams
Performance of AI-QCA predicting for PET-driven RFR
Time frame: Immediate after AI-QCA and PET exams
Performance of AI-QCA predicting for PET-driven stress MBF
Time frame: Immediate after AI-QCA and PET exams
Performance of AI-QCA predicting for PET-driven CFR
Time frame: Immediate after AI-QCA and PET exams
Performance of AI-QCA predicting for PET-driven CFC
Time frame: Immediate after AI-QCA and PET exams
Performance of AI-QCA predicting for PET-driven semi-quantitative markers of ischemia
Time frame: 1 year after last patient enrollment
All-cause death
Time frame: 1 year after last patient enrollment
Cardiovascular death
Time frame: 1 year after last patient enrollment
Any myocardial infarction, defined by Forth Universal definition of myocardial infarction
Time frame: 1 year after last patient enrollment
Target lesion revascularization
Time frame: 1 year after last patient enrollment
Target vessel revascularization
Time frame: 1 year after last patient enrollment
Any revascularization
Time frame: 1 year after last patient enrollment
Definite or probable stent thrombosis, defined by ARC II definition
Time frame: 1 year after last patient enrollment
Cerebrovascular accident
Time frame: 1 year after last patient enrollment
A composite of death, myocardial infarction, any revascularization, and cerebrovascular accident
Chonnam National University Hospital
Other
Relation Between Artificial Intelligence (AI)-Assisted Quantitative Coronary Angiography and Positron Emission Tomography-Derived Myocardial Blood Flow
Acronym: AI-CARPET
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06281041
Arterial Occlusive Diseases, Arteriosclerosis
Gwangju, South Korea
View Trial DetailsNCT05804500
Angina Pectoris, Angina, Stable
Washington D.C., District of Columbia, United States
View Trial DetailsNCT01106534
Arterial Occlusive Diseases, Arteriosclerosis
Birmingham, Alabama, United States
View Trial DetailsNCT02173379
Arterial Occlusive Diseases, Arteriosclerosis
Birmingham, Alabama, United States
View Trial Details